Stage IIIB Breast Cancer Suspended Phase 2 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs